GlobeNewswire 2011-10-25 GAM Holding AG: Interim management statement for the period to 30 September 2011
GlobeNewswire 2011-08-23 GAM Holding AG reports underlying net profit of CHF 100.4 million for the first half of 2011
GlobeNewswire 2011-04-19 Annual General Meeting of GAM Holding AG
GlobeNewswire 2011-04-19 GAM Holding AG: Interim management statement for the period to 31 March 2011
GlobeNewswire 2011-03-01 GAM Holding AG reports underlying net profit of CHF 202.2 million for 2010, up 35% year-on-year
GlobeNewswire 2010-11-15 Interim management statement for the period to 30 September 2010
GlobeNewswire 2010-08-24 GAM Holding AG reports net profit of CHF 106.3 million
GlobeNewswire 2010-03-12 GAM Holding Ltd. nominates Diego du Monceau for election to the Board of Directors
GlobeNewswire 2010-03-02 GAM Holding Ltd: 2009 full-year results
GlobeNewswire 2009-12-08 Actelion's selective S1P1 receptor agonist moves into advanced clinical development in psoriasis - P...
GlobeNewswire 2009-11-19 US Food and Drug Administration grants priority review for Actelion's miglustat in Niemann-Pick type...
GlobeNewswire 2009-11-17 Interim Management Statement for the period to 31 October 2009
GlobeNewswire 2009-10-30 Sika gains market share and reduces costs
GlobeNewswire 2009-10-20 Actelion announces 9-month financial results 2009
GlobeNewswire 2009-10-15 Actelion to discuss 9-month financial results 2009
GlobeNewswire 2009-10-09 Dose-finding Phase IIb study started in patients with multiple sclerosis - Actelion/Roche S1P1 allia...
GlobeNewswire 2009-09-30 Sika: structural adjustments to increase efficiency
GlobeNewswire 2009-09-24 Sika expands its concrete admixtures business in Eastern China
GlobeNewswire 2009-08-10 Tracleer receives label extension in the US for the treatment of patients with mildly symptomatic WH...
GlobeNewswire 2009-08-10 Ventavis (Iloprost) in pulmonary arterial hypertension receives US approval for increased 20 mcg/ml ...
GlobeNewswire 2009-07-31 Half-Year Report 2009: Sika shows fortitude in a tough market environment
GlobeNewswire 2009-07-21 Actelion announces Half Year financial results 2009
GlobeNewswire 2009-07-17 Actelion's PGI2 receptor agonist demonstrates efficacy in pulmonary arterial hypertension patients -...
GlobeNewswire 2009-07-15 Actelion to discuss Half Year financial results 2009
GlobeNewswire 2009-07-06 Tracleer (bosentan) receives EU approval for pediatric formulation - the first and only licensed pul...